Prof. Dr. Siegfried Priglinger

Siegfried Priglinger is the Director of the University Eye Hospital of the LMU and a leading vitreo-retinal specialist. He was the first to administer the marketed retinal gene therapy voretigene neparvovec (Luxturna) in Germany. He will contribute gene therapy-focused imaging know-how to help establishing optimal clinical readouts for gene therapy trials.